Zydus Lifesciences submits press release

10 Jun 2023 Evaluate

Zydus Lifesciences has submitted the press release that Zydus receives final approval from the USFDA for Balsalazide Disodium Capsules USP, 750 mg.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

925.95 -10.35 (-1.11%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.